RxDoctor Payments Data

Johanna Maggio

Adult Health · Murrells Inlet, SCNPI 1053729616

Payments from drug & device makers

$864in general payments, 2019–2025

Across 26 payments — averaging $33.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$209
  • Novo Nordisk$202
  • Gilead$166
  • Braeburn Inc.$75
  • Viiv Healthcare Company$61
  • Indivior Inc.$44
  • plus $107 from 5 others

What the payments were for

  • Food & beverage$864100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$864 in reported general payments places this provider in the 50th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina

Medicare billing

Part B allowed, 2024
$49,359
Medicare patients
318
Services billed
767

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide18$18,435
TrulicityDulaglutide13$12,298
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$2,541
SynthroidLevothyroxine Sodium12$1,549
Rosuvastatin Calcium12$514
Estradiol11$437
Omeprazole22$404
Atorvastatin Calcium39$230
Lisinopril30$226
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav31$212
Metoprolol Succinate16$194
Amlodipine Besylate12$193
Cefdinir12$192
Prednisone93$174
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$209$30,73331 claims
AbbVieSynthroid$18$1,54912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 292 adult health providers in South Carolina.

Other adult health in Murrells Inlet

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →